Latest / Health and life sciences
Trial finds GPT-4 access did not improve doctors’ diagnoses, but GPT-4 alone scored higher
See how this story connectsA randomised trial led by Stanford researchers, published in JAMA Network Open on 28 October 2024, gave 50 physicians ChatGPT Plus (GPT-4) or conventional resources for up to six clinical vignettes. Diagnostic reasoning scores were 76% with the chatbot and 74% without, a difference that was not significant. GPT-4 working alone scored 16 percentage points higher than the doctors using conventional resources.
Why it matters
Hospitals giving clinicians chatbots had trial evidence that access alone did not raise diagnostic scores, while the model working alone scored higher than unaided doctors.
- When
- 28 Oct 2024
- ID
WTA-N-2024-0015- Where
- United States
- Who
- Stanford University, OpenAI
- Topics
- Clinical AI, Safety testing
Summary by wheresthe.ai, from JAMA Network Open. Checked against the source on 9 Oct 2026.
Source copy: download the page as saved on 21 Oct 2026 (PDF). Also held by the Internet Archive.
Cite this story
WTA-N-2024-0015: “Trial finds GPT-4 access did not improve doctors’ diagnoses, but GPT-4 alone scored higher.” wheresthe.ai, 28 Oct 2024. https://wheresthe.ai/d/us-jama-llm-diagnostic-reasoning-rct-2024-10/ (source: JAMA Network Open (doi:10.1001/jamanetworkopen.2024.40969)).
Spotted an error? Email [email protected].